We offer tests tailored to your needs, from screening tests to application tests!
Inari Research supports toxicity testing from the screening phase to the entry into clinical trials (clinical studies). In addition to application tests in accordance with guidelines, our staff, who have extensive experience and achievements, will also handle screening tests. We conduct our tests at a GLP-compliant facility that has obtained certification from AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International). A series of non-clinical test sets, including genotoxicity tests and safety pharmacology tests necessary to enter clinical trials (Phase I), can be completed with the final report prepared within six months. 【Genotoxicity Tests】 ■ Reverse mutation test (Ames test) ■ In vitro / in vivo chromosome aberration tests ■ In vitro / in vivo micronucleus tests ■ Phototoxicity tests (3T3 cells) ■ In vivo comet assay *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is located in the nature-rich city of Ina, Nagano Prefecture, surrounded by two Alps, and has been serving our customers as a non-clinical trial contract research organization (CRO) for 50 years. Since 2022, we have become a member of the Shin Nippon Science Group, expanding and enhancing our contract testing items and analyses, and we can quickly respond to the procurement of various testing materials (such as animals). Non-Clinical Trial Business We accept safety and efficacy testing for pharmaceuticals, chemicals, pesticides, food, medical devices, and more. We conduct in vivo tests using small animals, rabbits, dogs, and monkeys, as well as in vitro tests using bacteria and cells, and various alternative method tests. Additionally, we specialize in the creation of SEND data required for FDA applications for new drugs, and we also undertake work related to SEND conversion and QC for data creation and conversion only. Our facility was the first in Japan to obtain full accreditation from AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International), and we are committed to international standards of animal welfare. We also propose tests necessary for various applications and registrations in compliance with regulations in different countries and regions.